Harbour BioMed raises $85 mln
Harbour BioMed said Aug. 27 that it raised $85 million in a Series B round led by GIC Private Ltd. New investors, including China Life Private Equity Investment Co and Vertex Ventures, along with Series A investors AdvanTech and Legend Capital also participated. Harbour BioMed is a biopharmaceutical company that is developing therapeutics for oncology and immunological diseases.
27 August 2018•3 mins read
